Loading…

Prostacyclin analogs stimulate VEGF production from human lung fibroblasts in culture

1 Division of Pulmonary Medicine, Nippon Medical School, Tokyo, Japan; 2 Pulmonary and Critical Care Medicine, University of Nebraska Medical Center, Omaha, Nebraska; 3 The Third Department of Internal Medicine, Wakayama Medical University, Wakayama, Japan; 4 Department of Respiratory Medicine, Junt...

Full description

Saved in:
Bibliographic Details
Published in:American journal of physiology. Lung cellular and molecular physiology 2008-06, Vol.294 (6), p.L1226-L1232
Main Authors: Kamio, Koichiro, Sato, Tadashi, Liu, Xiangde, Sugiura, Hisatoshi, Togo, Shinsaku, Kobayashi, Tetsu, Kawasaki, Shin, Wang, Xingqi, Mao, Lijun, Ahn, Youngsoo, Holz, Olaf, Magnussen, Helgo, Rennard, Stephen I
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c484t-8822fb051ffe9c5270dbfc50345fa261f954f86904018461594845699a57d5313
cites cdi_FETCH-LOGICAL-c484t-8822fb051ffe9c5270dbfc50345fa261f954f86904018461594845699a57d5313
container_end_page L1232
container_issue 6
container_start_page L1226
container_title American journal of physiology. Lung cellular and molecular physiology
container_volume 294
creator Kamio, Koichiro
Sato, Tadashi
Liu, Xiangde
Sugiura, Hisatoshi
Togo, Shinsaku
Kobayashi, Tetsu
Kawasaki, Shin
Wang, Xingqi
Mao, Lijun
Ahn, Youngsoo
Holz, Olaf
Magnussen, Helgo
Rennard, Stephen I
description 1 Division of Pulmonary Medicine, Nippon Medical School, Tokyo, Japan; 2 Pulmonary and Critical Care Medicine, University of Nebraska Medical Center, Omaha, Nebraska; 3 The Third Department of Internal Medicine, Wakayama Medical University, Wakayama, Japan; 4 Department of Respiratory Medicine, Juntendo University School of Medicine, Tokyo, Japan; 5 The Third Department of Internal Medicine, Mie University Graduate School of Medicine, Mie, Japan; 6 Department of Respiratory Medicine, The University of Tokyo Hospital, Tokyo, Japan; 7 Department of Rheumatology, Peking University Third Hospital, Beijing, China; and 8 Center for Pneumology and Thoracic Surgery, Hospital Grosshansdorf, Grosshansdorf, Germany Submitted 2 April 2007 ; accepted in final form 9 April 2008 Prostacyclin is a short-lived metabolite of arachidonic acid that is produced by several cells in the lung and prominently by endothelial cells. It increases intracellular cAMP levels activating downstream signaling thus regulating vascular mesenchymal cell functions. The alveolar wall contains a rich capillary network as well as a population of mesenchymal cells, i.e., fibroblasts. The current study evaluated the hypothesis that prostacyclin may mediate signaling between endothelial and mesenchymal cells in the alveolar wall by assessing the ability of prostacyclin analogs to modulate fibroblast release of VEGF. To accomplish this study, human lung fibroblasts were cultured in routine culture on plastic support and in three-dimensional collagen gels with or without three prostacyclin analogs, carbaprostacyclin, iloprost, and beraprost, and the production of VEGF was evaluated by ELISA and quantitative real-time PCR. Iloprost and beraprost significantly stimulated VEGF mRNA levels and protein release in a concentration-dependent manner. These effects were blocked by the adenylate cyclase inhibitor SQ-22536 and by the protein kinase A (PKA) inhibitor KT-5720 and were reproduced by a direct PKA activator but not by an activator of exchange protein directly activated by cAMP (Epac), indicating that cAMP-activated PKA signaling mediated the effect. Since VEGF serves to maintain the pulmonary microvasculature, the current study suggests that prostacyclin is part of a bidirectional signaling network between the mesenchymal and vascular cells of the alveolar wall. Prostacyclin analogs, therefore, have the potential to modulate the maintenance of the pulmonary microcirculation by driving the production o
doi_str_mv 10.1152/ajplung.00129.2007
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmed_primary_18424619</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>71625945</sourcerecordid><originalsourceid>FETCH-LOGICAL-c484t-8822fb051ffe9c5270dbfc50345fa261f954f86904018461594845699a57d5313</originalsourceid><addsrcrecordid>eNp1kM1uEzEUhS0EoqXwAiyQxaK7Cdce2xmzQ1VTkCK1i7ZbyzNjJxN5xoN_BHn7OiT8CKkrW_L5ju_9EHpPYEEIp5_0bnZ52iwACJULCrB8gc7LA60IB_ay3IFBBQL4GXoT4w4AOIB4jc5IwygTRJ6jh7vgY9LdvnPDhPWknd9EHNMwZqeTwY_XNys8B9_nLg1-wjb4EW_zqCd8-BvboQ2-dTqmiEtBl13KwbxFr6x20bw7nRfoYXV9f_W1Wt_efLv6sq461rBUNQ2ltgVOrDWy43QJfWs7DjXjVlNBrOTMNkKWNcrEgnBZMC6k1HzZ85rUF-jy2Fsm_J5NTGocYmec05PxOaolEbRAvAQ__hfc-RzKtlFRArKmNZclRI-hrjiJwVg1h2HUYa8IqINxdTKufhlXB-MF-nBqzu1o-r_ISXEJLI6B7bDZ_hiCUfN2HwdfRO__FFLJlFBrQqkowOfngVV27t78TL_Jf0A197Z-Ao9SoqQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>210932359</pqid></control><display><type>article</type><title>Prostacyclin analogs stimulate VEGF production from human lung fibroblasts in culture</title><source>American Physiological Society Free</source><creator>Kamio, Koichiro ; Sato, Tadashi ; Liu, Xiangde ; Sugiura, Hisatoshi ; Togo, Shinsaku ; Kobayashi, Tetsu ; Kawasaki, Shin ; Wang, Xingqi ; Mao, Lijun ; Ahn, Youngsoo ; Holz, Olaf ; Magnussen, Helgo ; Rennard, Stephen I</creator><creatorcontrib>Kamio, Koichiro ; Sato, Tadashi ; Liu, Xiangde ; Sugiura, Hisatoshi ; Togo, Shinsaku ; Kobayashi, Tetsu ; Kawasaki, Shin ; Wang, Xingqi ; Mao, Lijun ; Ahn, Youngsoo ; Holz, Olaf ; Magnussen, Helgo ; Rennard, Stephen I</creatorcontrib><description>1 Division of Pulmonary Medicine, Nippon Medical School, Tokyo, Japan; 2 Pulmonary and Critical Care Medicine, University of Nebraska Medical Center, Omaha, Nebraska; 3 The Third Department of Internal Medicine, Wakayama Medical University, Wakayama, Japan; 4 Department of Respiratory Medicine, Juntendo University School of Medicine, Tokyo, Japan; 5 The Third Department of Internal Medicine, Mie University Graduate School of Medicine, Mie, Japan; 6 Department of Respiratory Medicine, The University of Tokyo Hospital, Tokyo, Japan; 7 Department of Rheumatology, Peking University Third Hospital, Beijing, China; and 8 Center for Pneumology and Thoracic Surgery, Hospital Grosshansdorf, Grosshansdorf, Germany Submitted 2 April 2007 ; accepted in final form 9 April 2008 Prostacyclin is a short-lived metabolite of arachidonic acid that is produced by several cells in the lung and prominently by endothelial cells. It increases intracellular cAMP levels activating downstream signaling thus regulating vascular mesenchymal cell functions. The alveolar wall contains a rich capillary network as well as a population of mesenchymal cells, i.e., fibroblasts. The current study evaluated the hypothesis that prostacyclin may mediate signaling between endothelial and mesenchymal cells in the alveolar wall by assessing the ability of prostacyclin analogs to modulate fibroblast release of VEGF. To accomplish this study, human lung fibroblasts were cultured in routine culture on plastic support and in three-dimensional collagen gels with or without three prostacyclin analogs, carbaprostacyclin, iloprost, and beraprost, and the production of VEGF was evaluated by ELISA and quantitative real-time PCR. Iloprost and beraprost significantly stimulated VEGF mRNA levels and protein release in a concentration-dependent manner. These effects were blocked by the adenylate cyclase inhibitor SQ-22536 and by the protein kinase A (PKA) inhibitor KT-5720 and were reproduced by a direct PKA activator but not by an activator of exchange protein directly activated by cAMP (Epac), indicating that cAMP-activated PKA signaling mediated the effect. Since VEGF serves to maintain the pulmonary microvasculature, the current study suggests that prostacyclin is part of a bidirectional signaling network between the mesenchymal and vascular cells of the alveolar wall. Prostacyclin analogs, therefore, have the potential to modulate the maintenance of the pulmonary microcirculation by driving the production of VEGF from lung fibroblasts. tissue repair; vascular endothelial growth factor Address for reprint requests and other correspondence: S. I. Rennard, Univ. of Nebraska Medical Center, 985885 Nebraska Medical Center, Omaha, NE 68198-5885 (e-mail: srennard{at}unmc.edu )</description><identifier>ISSN: 1040-0605</identifier><identifier>EISSN: 1522-1504</identifier><identifier>DOI: 10.1152/ajplung.00129.2007</identifier><identifier>PMID: 18424619</identifier><language>eng</language><publisher>United States: American Physiological Society</publisher><subject>Adenine - analogs &amp; derivatives ; Adenine - pharmacology ; Adenylyl Cyclase Inhibitors ; Adenylyl Cyclases - physiology ; Adult ; Carbazoles - pharmacology ; Cell Culture Techniques ; Cells ; Cells, Cultured ; Epoprostenol - analogs &amp; derivatives ; Epoprostenol - pharmacology ; Fibroblasts - drug effects ; Fibroblasts - metabolism ; Humans ; Iloprost - pharmacology ; Kinases ; Lung - cytology ; Lungs ; Prostaglandins I - pharmacology ; Pyrroles - pharmacology ; RNA, Messenger - metabolism ; Signal transduction ; Stimulation, Chemical ; Studies ; Vascular Endothelial Growth Factor A - biosynthesis</subject><ispartof>American journal of physiology. Lung cellular and molecular physiology, 2008-06, Vol.294 (6), p.L1226-L1232</ispartof><rights>Copyright American Physiological Society Jun 2008</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c484t-8822fb051ffe9c5270dbfc50345fa261f954f86904018461594845699a57d5313</citedby><cites>FETCH-LOGICAL-c484t-8822fb051ffe9c5270dbfc50345fa261f954f86904018461594845699a57d5313</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18424619$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kamio, Koichiro</creatorcontrib><creatorcontrib>Sato, Tadashi</creatorcontrib><creatorcontrib>Liu, Xiangde</creatorcontrib><creatorcontrib>Sugiura, Hisatoshi</creatorcontrib><creatorcontrib>Togo, Shinsaku</creatorcontrib><creatorcontrib>Kobayashi, Tetsu</creatorcontrib><creatorcontrib>Kawasaki, Shin</creatorcontrib><creatorcontrib>Wang, Xingqi</creatorcontrib><creatorcontrib>Mao, Lijun</creatorcontrib><creatorcontrib>Ahn, Youngsoo</creatorcontrib><creatorcontrib>Holz, Olaf</creatorcontrib><creatorcontrib>Magnussen, Helgo</creatorcontrib><creatorcontrib>Rennard, Stephen I</creatorcontrib><title>Prostacyclin analogs stimulate VEGF production from human lung fibroblasts in culture</title><title>American journal of physiology. Lung cellular and molecular physiology</title><addtitle>Am J Physiol Lung Cell Mol Physiol</addtitle><description>1 Division of Pulmonary Medicine, Nippon Medical School, Tokyo, Japan; 2 Pulmonary and Critical Care Medicine, University of Nebraska Medical Center, Omaha, Nebraska; 3 The Third Department of Internal Medicine, Wakayama Medical University, Wakayama, Japan; 4 Department of Respiratory Medicine, Juntendo University School of Medicine, Tokyo, Japan; 5 The Third Department of Internal Medicine, Mie University Graduate School of Medicine, Mie, Japan; 6 Department of Respiratory Medicine, The University of Tokyo Hospital, Tokyo, Japan; 7 Department of Rheumatology, Peking University Third Hospital, Beijing, China; and 8 Center for Pneumology and Thoracic Surgery, Hospital Grosshansdorf, Grosshansdorf, Germany Submitted 2 April 2007 ; accepted in final form 9 April 2008 Prostacyclin is a short-lived metabolite of arachidonic acid that is produced by several cells in the lung and prominently by endothelial cells. It increases intracellular cAMP levels activating downstream signaling thus regulating vascular mesenchymal cell functions. The alveolar wall contains a rich capillary network as well as a population of mesenchymal cells, i.e., fibroblasts. The current study evaluated the hypothesis that prostacyclin may mediate signaling between endothelial and mesenchymal cells in the alveolar wall by assessing the ability of prostacyclin analogs to modulate fibroblast release of VEGF. To accomplish this study, human lung fibroblasts were cultured in routine culture on plastic support and in three-dimensional collagen gels with or without three prostacyclin analogs, carbaprostacyclin, iloprost, and beraprost, and the production of VEGF was evaluated by ELISA and quantitative real-time PCR. Iloprost and beraprost significantly stimulated VEGF mRNA levels and protein release in a concentration-dependent manner. These effects were blocked by the adenylate cyclase inhibitor SQ-22536 and by the protein kinase A (PKA) inhibitor KT-5720 and were reproduced by a direct PKA activator but not by an activator of exchange protein directly activated by cAMP (Epac), indicating that cAMP-activated PKA signaling mediated the effect. Since VEGF serves to maintain the pulmonary microvasculature, the current study suggests that prostacyclin is part of a bidirectional signaling network between the mesenchymal and vascular cells of the alveolar wall. Prostacyclin analogs, therefore, have the potential to modulate the maintenance of the pulmonary microcirculation by driving the production of VEGF from lung fibroblasts. tissue repair; vascular endothelial growth factor Address for reprint requests and other correspondence: S. I. Rennard, Univ. of Nebraska Medical Center, 985885 Nebraska Medical Center, Omaha, NE 68198-5885 (e-mail: srennard{at}unmc.edu )</description><subject>Adenine - analogs &amp; derivatives</subject><subject>Adenine - pharmacology</subject><subject>Adenylyl Cyclase Inhibitors</subject><subject>Adenylyl Cyclases - physiology</subject><subject>Adult</subject><subject>Carbazoles - pharmacology</subject><subject>Cell Culture Techniques</subject><subject>Cells</subject><subject>Cells, Cultured</subject><subject>Epoprostenol - analogs &amp; derivatives</subject><subject>Epoprostenol - pharmacology</subject><subject>Fibroblasts - drug effects</subject><subject>Fibroblasts - metabolism</subject><subject>Humans</subject><subject>Iloprost - pharmacology</subject><subject>Kinases</subject><subject>Lung - cytology</subject><subject>Lungs</subject><subject>Prostaglandins I - pharmacology</subject><subject>Pyrroles - pharmacology</subject><subject>RNA, Messenger - metabolism</subject><subject>Signal transduction</subject><subject>Stimulation, Chemical</subject><subject>Studies</subject><subject>Vascular Endothelial Growth Factor A - biosynthesis</subject><issn>1040-0605</issn><issn>1522-1504</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><recordid>eNp1kM1uEzEUhS0EoqXwAiyQxaK7Cdce2xmzQ1VTkCK1i7ZbyzNjJxN5xoN_BHn7OiT8CKkrW_L5ju_9EHpPYEEIp5_0bnZ52iwACJULCrB8gc7LA60IB_ay3IFBBQL4GXoT4w4AOIB4jc5IwygTRJ6jh7vgY9LdvnPDhPWknd9EHNMwZqeTwY_XNys8B9_nLg1-wjb4EW_zqCd8-BvboQ2-dTqmiEtBl13KwbxFr6x20bw7nRfoYXV9f_W1Wt_efLv6sq461rBUNQ2ltgVOrDWy43QJfWs7DjXjVlNBrOTMNkKWNcrEgnBZMC6k1HzZ85rUF-jy2Fsm_J5NTGocYmec05PxOaolEbRAvAQ__hfc-RzKtlFRArKmNZclRI-hrjiJwVg1h2HUYa8IqINxdTKufhlXB-MF-nBqzu1o-r_ISXEJLI6B7bDZ_hiCUfN2HwdfRO__FFLJlFBrQqkowOfngVV27t78TL_Jf0A197Z-Ao9SoqQ</recordid><startdate>20080601</startdate><enddate>20080601</enddate><creator>Kamio, Koichiro</creator><creator>Sato, Tadashi</creator><creator>Liu, Xiangde</creator><creator>Sugiura, Hisatoshi</creator><creator>Togo, Shinsaku</creator><creator>Kobayashi, Tetsu</creator><creator>Kawasaki, Shin</creator><creator>Wang, Xingqi</creator><creator>Mao, Lijun</creator><creator>Ahn, Youngsoo</creator><creator>Holz, Olaf</creator><creator>Magnussen, Helgo</creator><creator>Rennard, Stephen I</creator><general>American Physiological Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7TS</scope><scope>7U7</scope><scope>C1K</scope><scope>7X8</scope></search><sort><creationdate>20080601</creationdate><title>Prostacyclin analogs stimulate VEGF production from human lung fibroblasts in culture</title><author>Kamio, Koichiro ; Sato, Tadashi ; Liu, Xiangde ; Sugiura, Hisatoshi ; Togo, Shinsaku ; Kobayashi, Tetsu ; Kawasaki, Shin ; Wang, Xingqi ; Mao, Lijun ; Ahn, Youngsoo ; Holz, Olaf ; Magnussen, Helgo ; Rennard, Stephen I</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c484t-8822fb051ffe9c5270dbfc50345fa261f954f86904018461594845699a57d5313</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Adenine - analogs &amp; derivatives</topic><topic>Adenine - pharmacology</topic><topic>Adenylyl Cyclase Inhibitors</topic><topic>Adenylyl Cyclases - physiology</topic><topic>Adult</topic><topic>Carbazoles - pharmacology</topic><topic>Cell Culture Techniques</topic><topic>Cells</topic><topic>Cells, Cultured</topic><topic>Epoprostenol - analogs &amp; derivatives</topic><topic>Epoprostenol - pharmacology</topic><topic>Fibroblasts - drug effects</topic><topic>Fibroblasts - metabolism</topic><topic>Humans</topic><topic>Iloprost - pharmacology</topic><topic>Kinases</topic><topic>Lung - cytology</topic><topic>Lungs</topic><topic>Prostaglandins I - pharmacology</topic><topic>Pyrroles - pharmacology</topic><topic>RNA, Messenger - metabolism</topic><topic>Signal transduction</topic><topic>Stimulation, Chemical</topic><topic>Studies</topic><topic>Vascular Endothelial Growth Factor A - biosynthesis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kamio, Koichiro</creatorcontrib><creatorcontrib>Sato, Tadashi</creatorcontrib><creatorcontrib>Liu, Xiangde</creatorcontrib><creatorcontrib>Sugiura, Hisatoshi</creatorcontrib><creatorcontrib>Togo, Shinsaku</creatorcontrib><creatorcontrib>Kobayashi, Tetsu</creatorcontrib><creatorcontrib>Kawasaki, Shin</creatorcontrib><creatorcontrib>Wang, Xingqi</creatorcontrib><creatorcontrib>Mao, Lijun</creatorcontrib><creatorcontrib>Ahn, Youngsoo</creatorcontrib><creatorcontrib>Holz, Olaf</creatorcontrib><creatorcontrib>Magnussen, Helgo</creatorcontrib><creatorcontrib>Rennard, Stephen I</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Physical Education Index</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of physiology. Lung cellular and molecular physiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kamio, Koichiro</au><au>Sato, Tadashi</au><au>Liu, Xiangde</au><au>Sugiura, Hisatoshi</au><au>Togo, Shinsaku</au><au>Kobayashi, Tetsu</au><au>Kawasaki, Shin</au><au>Wang, Xingqi</au><au>Mao, Lijun</au><au>Ahn, Youngsoo</au><au>Holz, Olaf</au><au>Magnussen, Helgo</au><au>Rennard, Stephen I</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prostacyclin analogs stimulate VEGF production from human lung fibroblasts in culture</atitle><jtitle>American journal of physiology. Lung cellular and molecular physiology</jtitle><addtitle>Am J Physiol Lung Cell Mol Physiol</addtitle><date>2008-06-01</date><risdate>2008</risdate><volume>294</volume><issue>6</issue><spage>L1226</spage><epage>L1232</epage><pages>L1226-L1232</pages><issn>1040-0605</issn><eissn>1522-1504</eissn><abstract>1 Division of Pulmonary Medicine, Nippon Medical School, Tokyo, Japan; 2 Pulmonary and Critical Care Medicine, University of Nebraska Medical Center, Omaha, Nebraska; 3 The Third Department of Internal Medicine, Wakayama Medical University, Wakayama, Japan; 4 Department of Respiratory Medicine, Juntendo University School of Medicine, Tokyo, Japan; 5 The Third Department of Internal Medicine, Mie University Graduate School of Medicine, Mie, Japan; 6 Department of Respiratory Medicine, The University of Tokyo Hospital, Tokyo, Japan; 7 Department of Rheumatology, Peking University Third Hospital, Beijing, China; and 8 Center for Pneumology and Thoracic Surgery, Hospital Grosshansdorf, Grosshansdorf, Germany Submitted 2 April 2007 ; accepted in final form 9 April 2008 Prostacyclin is a short-lived metabolite of arachidonic acid that is produced by several cells in the lung and prominently by endothelial cells. It increases intracellular cAMP levels activating downstream signaling thus regulating vascular mesenchymal cell functions. The alveolar wall contains a rich capillary network as well as a population of mesenchymal cells, i.e., fibroblasts. The current study evaluated the hypothesis that prostacyclin may mediate signaling between endothelial and mesenchymal cells in the alveolar wall by assessing the ability of prostacyclin analogs to modulate fibroblast release of VEGF. To accomplish this study, human lung fibroblasts were cultured in routine culture on plastic support and in three-dimensional collagen gels with or without three prostacyclin analogs, carbaprostacyclin, iloprost, and beraprost, and the production of VEGF was evaluated by ELISA and quantitative real-time PCR. Iloprost and beraprost significantly stimulated VEGF mRNA levels and protein release in a concentration-dependent manner. These effects were blocked by the adenylate cyclase inhibitor SQ-22536 and by the protein kinase A (PKA) inhibitor KT-5720 and were reproduced by a direct PKA activator but not by an activator of exchange protein directly activated by cAMP (Epac), indicating that cAMP-activated PKA signaling mediated the effect. Since VEGF serves to maintain the pulmonary microvasculature, the current study suggests that prostacyclin is part of a bidirectional signaling network between the mesenchymal and vascular cells of the alveolar wall. Prostacyclin analogs, therefore, have the potential to modulate the maintenance of the pulmonary microcirculation by driving the production of VEGF from lung fibroblasts. tissue repair; vascular endothelial growth factor Address for reprint requests and other correspondence: S. I. Rennard, Univ. of Nebraska Medical Center, 985885 Nebraska Medical Center, Omaha, NE 68198-5885 (e-mail: srennard{at}unmc.edu )</abstract><cop>United States</cop><pub>American Physiological Society</pub><pmid>18424619</pmid><doi>10.1152/ajplung.00129.2007</doi></addata></record>
fulltext fulltext
identifier ISSN: 1040-0605
ispartof American journal of physiology. Lung cellular and molecular physiology, 2008-06, Vol.294 (6), p.L1226-L1232
issn 1040-0605
1522-1504
language eng
recordid cdi_pubmed_primary_18424619
source American Physiological Society Free
subjects Adenine - analogs & derivatives
Adenine - pharmacology
Adenylyl Cyclase Inhibitors
Adenylyl Cyclases - physiology
Adult
Carbazoles - pharmacology
Cell Culture Techniques
Cells
Cells, Cultured
Epoprostenol - analogs & derivatives
Epoprostenol - pharmacology
Fibroblasts - drug effects
Fibroblasts - metabolism
Humans
Iloprost - pharmacology
Kinases
Lung - cytology
Lungs
Prostaglandins I - pharmacology
Pyrroles - pharmacology
RNA, Messenger - metabolism
Signal transduction
Stimulation, Chemical
Studies
Vascular Endothelial Growth Factor A - biosynthesis
title Prostacyclin analogs stimulate VEGF production from human lung fibroblasts in culture
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T11%3A34%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prostacyclin%20analogs%20stimulate%20VEGF%20production%20from%20human%20lung%20fibroblasts%20in%20culture&rft.jtitle=American%20journal%20of%20physiology.%20Lung%20cellular%20and%20molecular%20physiology&rft.au=Kamio,%20Koichiro&rft.date=2008-06-01&rft.volume=294&rft.issue=6&rft.spage=L1226&rft.epage=L1232&rft.pages=L1226-L1232&rft.issn=1040-0605&rft.eissn=1522-1504&rft_id=info:doi/10.1152/ajplung.00129.2007&rft_dat=%3Cproquest_pubme%3E71625945%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c484t-8822fb051ffe9c5270dbfc50345fa261f954f86904018461594845699a57d5313%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=210932359&rft_id=info:pmid/18424619&rfr_iscdi=true